Board of Scientific Counselors, National Center for Health Statistics, 79899-79900 [2015-32205]

Download as PDF Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices ‘‘FOA DP16–001, Panel D, Pregnancy Risk Assessment Monitoring System (PRAMS)’’. Contact Person for More Information: Jayalakshmi Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488– 6511, kva5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review tkelley on DSK3SPTVN1PROD with NOTICES Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–32210 Filed 12–22–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Board of Scientific Counselors, National Center for Health Statistics In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) announces the following meeting of the aforementioned committee. Times and Dates: 11:00 a.m.–5:30 p.m., EST, January 21, 2016. 8:30 a.m.–1:00 p.m., EST, January 22, 2016. Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782. Status: This meeting is open to the public; however, visitors must be processed in accordance with established federal policies and procedures. For foreign nationals or non-U.S. citizens, pre-approval is required (please contact Gwen Mustaf, 301–458–4500, glm4@cdc.gov, or Virginia Cain, vcain@cdc.gov at least 10 days in advance for requirements). All visitors are required to present a valid form of picture identification issued by a state, federal or international government. As required by the Federal Property Management Regulations, Title 41, Code of Federal Regulation, Subpart 101–20.301, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being x-rayed and inspected. Federal law prohibits the knowing possession or the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. The meeting room accommodates approximately 100 people. Purpose: This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP 16–001, Pregnancy Risk Assessment Monitoring System (PRAMS). Time and Date: 12:00 p.m.–6:00 p.m., EST, Panel B, February 2, 2016 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘FOA DP16–001, Panel B, Pregnancy Risk Assessment Monitoring System (PRAMS)’’. Contact Person for More Information: Jayalakshmi Raman, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Jkt 238001 [FR Doc. 2015–32208 Filed 12–22–15; 8:45 am] Centers for Disease Control and Prevention [FR Doc. 2015–32209 Filed 12–22–15; 8:45 am] 18:05 Dec 22, 2015 Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. VerDate Sep<11>2014 Georgia 30341, Telephone: (770) 488– 6511, kva5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 79899 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP 16–001, Pregnancy Risk Assessment Monitoring System (PRAMS). Times and Dates: 10:00 a.m.–6:00 p.m., EST, Panel A1, January 20–21, 2016 (Closed). 10:00 a.m.–6:00 p.m., EST, Panel A2, January 27–28, 2016 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘FOA DP16–001, Panel A, Pregnancy Risk Assessment Monitoring System (PRAMS)’’. Contact Person for More Information: Jayalakshmi Raman, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488– 6511, kva5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 E:\FR\FM\23DEN1.SGM 23DEN1 79900 Federal Register / Vol. 80, No. 246 / Wednesday, December 23, 2015 / Notices objectives, strategies, and priorities of NCHS. Matters for Discussion: The agenda will include: 1. Welcome remarks by the Director, NCHS 2. Presentation on ICD–10 3. Presentation on Health Interview Survey Content Redesign 4. Update on Office of Analysis and Epidemiology 5. Presentation on Web Survey Requests to make oral presentations should be submitted in writing to the contact person listed below. All requests must contain the name, address, telephone number, and organizational affiliation of the presenter. Written comments should not exceed five single-spaced typed pages in length and must be received by December 31, 2015. The agenda items are subject to change as priorities dictate. Contact Person For More Information: Virginia S. Cain, Ph.D., Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 7208, Hyattsville, Maryland 20782, telephone (301) 458– 4500, fax (301) 458–4024. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. PLACE: Hyatt Pittsburgh Airport, 1111 Airport Boulevard, Pittsburgh, Pennsylvania 15231. STATUS: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. MATTERS FOR DISCUSSION: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘PAR 15–361, NIOSH Centers of Excellence for Total Worker Health’’. CONTACT PERSON FOR MORE INFORMATION: Nina Turner, Ph.D., Scientific Review Officer, NIOSH, CDC, 1095 Willowdale Road, Mailstop G905, Morgantown, West Virginia 26506, Telephone: (304) 285–5976. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–32212 Filed 12–22–15; 8:45 am] BILLING CODE 4163–18–P Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2015–32205 Filed 12–22–15; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Centers for Disease Control and Prevention tkelley on DSK3SPTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to PAR 15–361, NIOSH Centers of Excellence for Total Worker Health. TIMES AND DATES: 8:00 a.m.–5:00 p.m., EST, March 16, 2016 (Closed). 8:00 a.m.–5:00 p.m., EST, March 17, 2016 (Closed). VerDate Sep<11>2014 18:05 Dec 22, 2015 Jkt 238001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcements (FOA) IP16–001, Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific and (FOA) IP16–002, Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States. Time and Date: 10:00 a.m.–5:00 p.m., EST, February 24–25, 2016 (Closed). PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c) (4) and (6), title 5 U.S.C., and the determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Research on the Epidemiology, Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in Southeast Asia and the Western Pacific’’, IP16–001 and ‘‘Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States’’, IP16– 002. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–32206 Filed 12–22–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) CK16–001, Emerging Infections Sentinel Networks (EISN) Research. Time and Date: 10:00 a.m.–5:00 p.m., January 28, 2016 (Closed). Place: Teleconference. E:\FR\FM\23DEN1.SGM 23DEN1

Agencies

[Federal Register Volume 80, Number 246 (Wednesday, December 23, 2015)]
[Notices]
[Pages 79899-79900]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32205]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Board of Scientific Counselors, National Center for Health 
Statistics

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), National Center for Health Statistics (NCHS) 
announces the following meeting of the aforementioned committee.
    Times and Dates: 11:00 a.m.-5:30 p.m., EST, January 21, 2016.
    8:30 a.m.-1:00 p.m., EST, January 22, 2016.
    Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 
20782.
    Status: This meeting is open to the public; however, visitors must 
be processed in accordance with established federal policies and 
procedures. For foreign nationals or non-U.S. citizens, pre-approval is 
required (please contact Gwen Mustaf, 301-458-4500, glm4@cdc.gov, or 
Virginia Cain, vcain@cdc.gov at least 10 days in advance for 
requirements). All visitors are required to present a valid form of 
picture identification issued by a state, federal or international 
government. As required by the Federal Property Management Regulations, 
Title 41, Code of Federal Regulation, Subpart 101-20.301, all persons 
entering in or on Federal controlled property and their packages, 
briefcases, and other containers in their immediate possession are 
subject to being x-rayed and inspected. Federal law prohibits the 
knowing possession or the causing to be present of firearms, explosives 
and other dangerous weapons and illegal substances. The meeting room 
accommodates approximately 100 people.
    Purpose: This committee is charged with providing advice and making 
recommendations to the Secretary, Department of Health and Human 
Services; the Director, CDC; and the Director, NCHS, regarding the 
scientific and technical program goals and

[[Page 79900]]

objectives, strategies, and priorities of NCHS.
    Matters for Discussion: The agenda will include:

1. Welcome remarks by the Director, NCHS
2. Presentation on ICD-10
3. Presentation on Health Interview Survey Content Redesign
4. Update on Office of Analysis and Epidemiology
5. Presentation on Web Survey

    Requests to make oral presentations should be submitted in writing 
to the contact person listed below. All requests must contain the name, 
address, telephone number, and organizational affiliation of the 
presenter.
    Written comments should not exceed five single-spaced typed pages 
in length and must be received by December 31, 2015.
    The agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Virginia S. Cain, Ph.D., 
Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 7208, 
Hyattsville, Maryland 20782, telephone (301) 458-4500, fax (301) 458-
4024.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-32205 Filed 12-22-15; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.